- Created by Sean Berryman, last modified on Jul 26, 2018
You are viewing an old version of this page. View the current version.
Compare with Current View Page History
« Previous Version 6 Next »
Summary
Nasopharyngeal carcinoma has a higher incidence in China, and it is more common in the southeast coast. MRI and PET-CT are indispensable imaging modalities that can more accurately assess the stage of tumor and guide the treatment planning and evaluation of normal tissue response. The Department of radiation oncology in our hospital has performed the treatment of nasopharyngeal cancer for many years. Has a wealth of clinical experience and a large number of nasopharyngeal carcinoma patients. Inclusion criteria: 1. All patients are pathologically confirmed nasopharyngeal carcinoma, 2. KPS score is larger than 60 and no other serious cardiovascular disease that could affect the course of treatment. Exclusion criteria: The expected survival time is less than 1 month, and the general condition is poor and radiotherapy cannot be completed. Take a CT, MRI and upload the data in imaging archive at the time before radiotherapy, during 15-20 fraction, 1 month after radiotherapy, 3 months after radiotherapy, 6 months after radiotherapy, 9 months after radiotherapy, 1 year after radiotherapy.
Nasopharyngeal carcinoma has a higher incidence rate in Taizhou city. Taizhou Hospital is the largest general hospital in the local region. It has the largest nasopharyngeal carcinoma resources and can represent the highest level of nasopharyngeal diagnosis and treatment in Taizhou. By analyzing our imaging data, we try to to investigate predictive and prognostic radiomic parameters of treatment and survival outcomes for IMRT treated NPC. Also we are going to correlate the difference in radiomic features between MRI and PET-CT scan in predicting treatment and survival outcomes.
Acknowledgements
Data Access
Choosing the Download option will provide you with a file to launch the TCIA Download Manager to download the entire collection. If you want to browse or filter the data to select only specific scans/studies please use the Search By Collection option.
Data Type | Download all or Query/Filter |
---|---|
Images (DICOM, GB) | |
Tissue Slide Images (web) | |
Clinical Data (CSV) | |
Genomics (web) |
Click the Versions tab for more info about data releases.
Detailed Description
Image Statistics |
|
---|---|
Modalities | CT, MR, PET, PET-CT |
Number of Patients | 400 |
Number of Studies | 2000 |
Number of Series | |
Number of Images | |
Images Size (GB) |
Citations & Data Usage Policy
Data Citation
Kirk, S., Lee, Y., Lucchesi, F. R., Aredes, N. D., Gruszauskas, N., Catto, J., … Lemmerman, J. (2016). Radiology Data from The Cancer Genome Atlas Urothelial Bladder Carcinoma [TCGA-BLCA] collection. The Cancer Imaging Archive. http://doi.org/10.7937/K9/TCIA.2016.8LNG8XDR
TCIA Citation
Clark K, Vendt B, Smith K, Freymann J, Kirby J, Koppel P, Moore S, Phillips S, Maffitt D, Pringle M, Tarbox L, Prior F. The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository, Journal of Digital Imaging, Volume 26, Number 6, December, 2013, pp 1045-1057. (paper)
Other Publications Using This Data
TCIA maintains a list of publications which leverage our data. At this time we are not aware of any manuscripts based on this data. If you have a manuscript you'd like to add please contact the TCIA Helpdesk.
- No labels